Sildenofil in Persistent Pulmonary Hypertension in Newborns

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01558466

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01558466
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Qatar (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01558466. Randomized; triple masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sildenofil in Persistent Pulmonary Hypertension in Newborns
Acronym
Sildeno
Condition
Persistent Fetal Circulation Syndrome
Intervention (Drug)
Sildenafil
Intervention (Drug)
diluent
Lead sponsor
Hamad Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct01558466
Content hash
a1c847553948e4e99df85d8bd70465df2fccc518f4cdd466af74aee2e73f94b3